Concepedia

Olga Ab

OA

Statistics

Publications

16

Citations

1.3K

H-Index

14

Active since

2004

Affiliations

ImmunoGen (United States)(Current)

Olga Ab is an author at ImmunoGen (United States) specializing in antibody-drug conjugates, cancer pharmacology, and antibody conjugates.

ORCID

Publications per year

2004–2022

16

Publications

16

Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance

Yelena Kovtun, Charlene A. Audette, Michele Mayo et al. · Cancer Research · 2010 · 259 citations

, , +16

Effects of Drug–Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody–Maytansinoid Conjugates

Xiuxia Sun, Jose F. Ponte, Nicholas C. Yoder et al. · Bioconjugate Chemistry · 2017 · 253 citations

, , +17

IMGN853, a Folate Receptor-α (FRα)–Targeting Antibody–Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors

Olga Ab, Kathleen R. Whiteman, Laura M. Bartle et al. · Molecular Cancer Therapeutics · 2015 · 224 citations

, , +17

A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells

Yelena Kovtun, Gregory E. Jones, Sharlene Adams et al. · Blood Advances · 2018 · 176 citations · Full text

, , +15

Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models

Jose F. Ponte, Olga Ab, Leanne Lanieri et al. · Neoplasia · 2016 · 112 citations · Full text

, , +16

1–5 of 16